SIGA Technologies Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 09/23/2026 16:00

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeNASDAQ

Market Capitalization225.61 mln

Float46.52 mln

Earnings Date11/05/2026

Business Description

SIGA Technologies is a New York-based pharmaceutical company founded in 1995, specializing in medicines designed to protect public health against serious biological threats. Its primary product, TPOXX, is an antiviral treatment developed to combat smallpox, a disease caused by the variola virus. The company sells its products primarily within the United States.

Key Fundamentals

EPS-0.04

ROE-1.50

RPS0.75

ROIC-12.35

ROA-1.29

EBITDA, mln-10.55

EV / EBITDA-9.81

EV / EBIT-9.29

Revenue, mln53.66

EV / Revenue1.93

Quote Details

Last 3.17

Change -0.09 (-2.76%)

Open 3.25

Volume 434,741

Turnover 1,378,129

Average Volume 656,699

Financial Ratios

Pre-Tax Profit Margin-10

Leverage Ratio1.06

Current Ratio21.72

Price / Book1.33

Price / Tangible Book1.34

Debt / Equity0.00

Price / Sales4.11

PEG Ratio3.37

Financial Strength

Altman Z-Score13.36

Piotroski F-Score 2 / 9

Beneish M-Score-0.21

Price to Intrinsic Value0.36

Shiller PE Ratio2.97

Short Ratio5.30

Short % of Float7.63

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	2.26%	72 / 100
1 Month	7.82%	88 / 100
2 Months	-26.28%	14 / 100
6 Months	-28.28%	15 / 100
1 Year	-61.76%	12 / 100

SIGA Technologies Inc

Company Profile

Piotroski F-Score

Beneish M-Score

Relative Strength

Debt / Equity